The Remington Group is committed to creating more survivors of heart disease and stroke. We don’t believe our genes should be our destiny, and that’s why our team is fundraising for the 2017 Ride for Heart on June 4th. Your donation will push forward life-saving research and fund incredible breakthroughs.
It was always apparent that family history played a role in risk factors for heart disease and stroke. But despite significant advances, we only know 20-30% of the genes involved.
With the right funding, doctors predict they could unlock the genetic puzzle behind cardiovascular disease within as little as 5 years.
Please help us with our fundraising goal and make a donation today.
We thank you for your support.